From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Hemogenyx – Vlad Sandler takes the piss again with another discounted placing

By Tom Winnifrith | Tuesday 11 March 2025


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Vlad earned £397,000 in 2023 so with employers taxes and expenses will have cost Hemogenyx (HEMO) close to half a Bernie. The two NEDS, Alex Sander and 196 year old Peter Redmond earned a combined £110,000 so will have cost at least £150,000 so the PLC costs of running this crock will be close to a Bernie. Not that it has actually made much progress in the labs.
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

BOOM

Evil’s Rule: Audioboom

 

URU…Who R U Kidding?

Sunday »

EZJ

BUY Easyjet

Time left: 20:45:50